Data file are available from the Zenodo database ([10.5281/zenodo.3598233](https://doi.org/10.5281/zenodo.3598233)).

1 Introduction {#sec001}
==============

Publishing research results in a recognized journal is the most accepted way of documenting the originality of the work and confirm that its results were good enough to overcome the skepticism of the scientific community and to be integrated into the knowledge of the area concerned. The need to publish has maintained journals as a key element of scientific research, even with all the technological and social changes of recent years \[[@pone.0233432.ref001]\], \[[@pone.0233432.ref002]\], \[[@pone.0233432.ref003]\], \[[@pone.0233432.ref004]\], \[[@pone.0233432.ref005]\], \[[@pone.0233432.ref006]\].

The essential role of journals as registries of scientific activity in all areas of knowledge justifies research on their management and the publishers that own them. The vital importance of publishing research results in terms of the prestige it gives researchers and institutions, and as a registration of copyright to a given finding for citing in subsequent studies, is a key feature of the communication of science \[[@pone.0233432.ref007]\], \[[@pone.0233432.ref008]\], \[[@pone.0233432.ref009]\], \[[@pone.0233432.ref010]\], \[[@pone.0233432.ref011]\].

Mathias, Jahn and Laakso (2019, p.5) \[[@pone.0233432.ref012]\] remind us that "journals do not exist in a vacuum, but within a dynamic environment characterized by competition for high-quality manuscripts. Since peer-reviewed publications are still the key to academic career progression, a journal's value is closely connected to the prestige it brings to authors."

Three major commercial publishers (Elsevier, Springer-Kluwer, and Wiley-Blackwell) own 42% of all published articles and the majority of the most prestigious and widely circulated journals in 2007. Another 2,000 publishers are responsible for all the rest, none with more than 3% of the total \[[@pone.0233432.ref013]\]. Half of all scientific publishing is controlled by a small group of commercial publishers who offer high-priced "big deals" to libraries, despite the increasing diversity of countries of the authors of scientific production \[[@pone.0233432.ref014]\], perpetuating the dominance of publication by the same titles and preventing the creation of new options in open access or in peripheral countries \[[@pone.0233432.ref015]\], \[[@pone.0233432.ref016]\], \[[@pone.0233432.ref017]\], \[[@pone.0233432.ref018]\]. This situation has given rise to complaints of abusive costs and cartelization practices \[[@pone.0233432.ref019]\], \[[@pone.0233432.ref020]\], \[[@pone.0233432.ref021]\]. Now, according to *Ulrich's directory*, the biggest publishers of academic journals are Elsevier (The Netherlands, about 4.700 journals), SpringerNature (United Kingdom, 4.200), Wiley (United States, 3.200), Routledge (UK, 3.100), Sage (United States, 2.300) and Taylor&Francis (United Kingdom, 2.200), considering all their different companies.

In the Open Access scene, a "study of 319 journals operated by four major commercial publishers, BMC, Frontiers, MDPI, and Hindawi, indicated that higher APCs are associated with higher article volumes." (Khoo, 2019, p. 10) \[[@pone.0233432.ref022]\]. The author identifies a high level of APCs hyperinflation in the new publishers' prices. The study shows the replication of the ligopoly existent in the traditional publishers in the new Open Access commercial publishers.

Beasley (2016, p. 167) \[[@pone.0233432.ref008]\] discusses the new models of scientific publications based on Open Access, arguing that large-scale creation of titles via the so-called "gold route" can \"perpetuate and even reinforce an already well-documented system of discrimination that excludes important groups from having their research disseminated through formal channels of scientific communication.\" Moreover, the fact that hybrid journals are already collecting APCs from authors raises the question of whether these journals should reduce their subscription prices to reflect the proportion of publication costs already paid by the author for the content \[[@pone.0233432.ref023]\].

Piwowar el al. (2018) \[[@pone.0233432.ref024]\] point out that there is significant literature on Open Access, but that the definitions are still fluid. These authors identify a large number of open access articles in a category they describe as "bronze", where the articles are free to read on the publishing institution\'s website but do not have a clearly identified license, which may complicate the identification of the articles as open. The definitions of types of access are still under discussion, and the authors point out that gold is one of the categories with the lowest number of articles identified, representing around 7.5% of the total sample, and with a wide range of APC values.

Piwowar, Priem and Orr (2019) \[[@pone.0233432.ref025]\] found that 20% of all articles were in open access in 2018, divided into four types of OA: gold, green, hybrid, and bronze. Since the focus here is on journals, we concentrate on the gold option. All the others are complementary, since the core of the change is the journals, with academic peer review and technical indexation, metadata and metrics provided by a publisher.

Aspesi et al. (2019) \[[@pone.0233432.ref026]\] detail the strategies of the big publishers to grow in the new scenario with open access journals and Plan S, which does not recognize either the embargo or the hybrid model as open. These commercial publishers are investing in academic management solutions using their data, creating new titles in open access and partnerships with educational and research institutions to publish their journals.

This study of the main publishers and their collections in the global scenario aims to assess concentration of ownership among the various players and countries in the Directory of Open Access Journals (DOAJ) database. We have chosen the DOAJ because it is a representative platform for Open Access publishers and journals and it has a policy of accepting only Open Access journals, while excluding titles that choose the embargo or the so-called hybrid model. The general objective of this research is to analyze the main characteristics of publishers holding the DOAJ Seal. The specific objectives are a) to identify publishers and journals registered with the DOAJ seal; b) to characterize those publishers (number of journals, number of articles, and knowledge area); and c) to analyze their article processing fees.

2 Methodology {#sec002}
=============

The DOAJ database was created in 2003 and includes almost 14,000 peer-reviewed open access journals covering all knowledge areas, published in 130 countries. There is a selective process to be followed to assure the quality of the titles and for this reason, DOAJ can be considered as a "white list" to confront supposed predatory publishing (i.e. a journal is not a predatory one if it's included in this directory).

DOAJ is maintained by Infrastructure Services for Open Access (IS4OA) and its funding is derived from donations (40% from publishers and 60% from the public sector). DOAJ introduced a quality distinction, called the DOAJ Seal, to identify the most prominent journals "that achieve a high level of openness, adhere to Best Practice and high publishing standards" (DOAJ) \[[@pone.0233432.ref027]\] (use of DOI, metadata in the articles, preservation policy, whether author holds copyright, whether reuse of content is allowed, etc.). There are 1354 journals (around 10% of the total) that have been awarded the Seal.

We chose to study the DOAJ Seal due to the large number of journals exclusively in Open Access and the rigorous criteria used to index the titles, which leaves little question of the quality of the publications. The search strategy involved using the Seal option, then ranking the journals to identify the biggest publishers, the number of journals and the number of articles in March 2019. We have extracted the following indicators from DOAJ: publisher, title, ISSN, country, number of articles, knowledge area (according to the DOAJ classification), value of article processing charges in USD, time for publication in weeks, and year of indexing in DOAJ.

For the descriptions of the publishers\' characteristics we consulted their websites.

3 Results and discussion {#sec003}
========================

The data shows a prevalence of commercial publishers, both traditional and new. We investigated both the number of titles and the number of articles, since these two categories reveal different influences on the scenario. The distribution of knowledge areas is in keeping with the relative prominence of the areas in the scientific world generally, with the highest number of titles falling into the area of medicine. Publishers and knowledge areas influence the value of APCs and the time for publication of the articles, expressed in weeks.

3.1 Publishers and titles registered with the DOAJ Seal {#sec004}
-------------------------------------------------------

The data shows 463 publishers registered in January 2019, 123 with three titles or less and 105 with just one journal. The titles are owned predominantly by four big publishers: BioMed Central, Hindawi Limited, Multidisciplinary Digital Publishing Institute (MDPI) and Springer Open. The companies Frontier Media S.A., Copernicus Publications, African Online Scientific Information System (AOSIS), and Nature Publishing Group form a second group with significant numbers of titles. On the other hand, *PLOS One* and *International Journal of Crystallography* each stand out for a high number of articles from a single journal.

If we consider the number of articles, the data shows a different configuration. The number of articles varies widely among journals and affects the representation of the publisher in the DOAJ database and in the "market". PLOS is the leader company, with 240,000 or 20% of all articles from just seven journals. The single journal *PLOS One* has almost as many articles as the collective total for 147 smaller publishers and more than any other single publisher. Despite its small number of titles, PLOS is certainly a central player in the Open Access oligopoly of publishers, along with Bio Med Central (Springer), Hindawi Limited and Multidisciplinary Digital Publishing Institute (MDPI), each of which have more than 180,000 articles. If we add up the articles of these four publishers, they are responsible for 807,271 out of a total of 1,257,208, almost 65% of the total, representing a concentration of ownership bigger than the one described by Larivière, Hautein and Mongeon (2015) \[[@pone.0233432.ref019]\] in a traditional scenario.

[Table 1](#pone.0233432.t001){ref-type="table"} identifies three models of publishers in the Open Access world: a) expansion through the number of journals; b) expansion through the number of articles in few journals; and c) creation of an "open" division by a traditional publisher. The best examples of the first model are Biomed Central, MDPI and Hindawi, companies that began as digital publishers. *PLOS One*, the pioneer of the mega journal, is emblematic of the second model, beginning as a journal in 2003 and introducing two significant changes to academic publishing: an expansion of the number of articles per title, and the elimination of "novelty" from the publishing criteria: "We evaluate submitted manuscripts on the basis of methodological rigor and high ethical standards, regardless of perceived novelty" \[[@pone.0233432.ref028]\].

10.1371/journal.pone.0233432.t001

###### Biggest publishers: Distribution of titles and articles.
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  Publishers                                                                          Titles                     \%       Articles    \%
  ----------------------------------------------------------------------------------- -------------------------- -------- ----------- ------
  Bio Med Central (Springer) United Kingdom, 1999                                     **Total** 294              21.3     183534      15
  *BMC Public Health*                                                                                            8639                 
  *BMC Genomics*                                                                                                 6695                 
  Others (292)                                                                                                   168200               
  Hindawi Limited [\*](#t001fn002){ref-type="table-fn"} United Kingdom, Egypt, 1997   **Total** 227              16.4     186847      15.3
  *BioMed Research International*                                                                                15667                
  *Mathematical Problems in Engineering*                                                                         14241                
  Others (225)                                                                                                   156939               
  Multidisciplinary Digital Publishing Institute (MDPI) Switzerland, 1996             **Total** 173              12.5     197265      16.2
  *Sensors*                                                                                                      17945                
  *International Journal of Molecular Sciences*                                                                  17123                
  Others (171)                                                                                                   162167               
  Springer Open United Kingdom, 2010                                                  **Total** 170              12.3     35753       2.9
  *Journal of High Energy Physics*                                                                               4180                 
  *Journal on Advances in Signal Processing*                                                                     3711                 
  Others (168)                                                                                                   27862                
  Frontiers Media S.A.[\*\*](#t001fn003){ref-type="table-fn"} Switzerland, 2007       **Total** 53               3.8      102732      8.4
  *Frontiers in Psychology*                                                                                      12674                
  *Frontiers in Microbiology*                                                                                    10933                
  Others (51)                                                                                                    79125                
  Public Library of Science (PLOS) The United States of America, 2003                 **Total** 7                0.5      239625      19.6
  *PLOS ONE*                                                                                                     202825               
  *PLOS Genetics*                                                                                                7908                 
  Others (5)                                                                                                     28892                
  Copernicus Publications Germany, 1988                                               **Total** 38               2.7      54873       4.5
  Nature (Springer) United Kingdom, 1869                                              **Total** 22               1.6      23634       1.9
  OTHERS (147)                                                                        *Acta Crystallographica*   0.3      22728       2.2
                                                                                      Others (359)               26       288724      11.7
  Total                                                                               1,390                      100      1,257,208   100

Data collected by the authors

\* Hindawi mentions a partnership with Wiley

\*\* Frontiers Media reports investments from Springer/Nature, although are identified as separate companies.

There is also what could be described as a mixed model, where a publisher with a high number of titles has a few with a much higher number of articles, but in a specific knowledge area, like Hindawi with *BioMed Research International* and *Mathematical Problems in Engineering*, and MDPI with *Sensors* and *International Journal of Molecular Sciences*. Ellers, Crowther and Harvey (2017, p. 91) \[[@pone.0233432.ref029]\] suggest that the higher number of articles are due to the fact that a "rejection of manuscripts is a cost factor for an open access journal with the author-pays system because rejected manuscripts need to be handled but do not generate income. This is one of the reasons why highly selective journals rarely adopt OAP, as their stringent acceptance rates would render OAP unprofitable."

Springer is responsible for 35% of the titles indexed with the DOAJ Seal, reflecting an even bigger oligopoly than the one identified in the general scientific publishing market \[[@pone.0233432.ref019]\], and more than the total of titles belonging to all the small publishers. The Springer case, expanding the Open Access model through acquisitions and the creation of a new company while maintaining a traditional subscription structure, is one reason for the slow progress in advancing OA, which Mathias, Jahn and Laakso (2019, p. 2) \[[@pone.0233432.ref012]\] describe as "an issue long discussed and recognized among all stakeholders". These authors add that "\[f\]urther delaying the conversion of subscription journals, or rapid adoption of new OA journals as substitutes, is the lack of incentives for publishers to accelerate this process and discard what has proven to be a highly profitable and stable business model."

Hindawi, MDPI, AOSIS and PLOS are new companies created after the Open Access movement began. Hindawi works with its own journals and in partnership with other publishers; MDPI has its own journals, partnerships with scientific societies, a preprint structure and open books; AOSIS, which is based in South Africa, publishes scholarly journals, books and educational content using Moodle.

Studies using DOIs as a source of information show a more significant number for OA because the unit of analysis is different: all DOIs, without distinguishing the period and indexation of the journals and repositories are included. This method is unsuitable if we are looking exclusively for high-quality research results. Gold Open Access titles represented only 8% of all journals in 2018 \[[@pone.0233432.ref026]\]. An analysis of revenues confirms the small scale of their share in the market: less than U\$500 million in 2017, or about 5% of the total, 15 years after the Budapest Open Access Declaration was signed \[[@pone.0233432.ref025]\].

1.  The growth in the number of titles from 2010 to 2019 ([Table 2](#pone.0233432.t002){ref-type="table"}) varies widely among publishers: Springer Open increased its number of journals by 840%, while growth for MDPI was 540% in a media growth of 190% over an eight-year period. This reflects a clear strategy to fill the market with new titles. Springer Open, BioMed Central, and Nature Publishing are the same company, constituting a mix of spinoff publishers and mergers to operate in the open access market while maintaining the traditional publishing company.

10.1371/journal.pone.0233432.t002

###### Number of titles awarded the DOAJ Seal since 2010, organized by publisher.
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  Publisher                                               Until 2010   2011   2012   2013   2014   2015   2016   2017   2018   Total   Growth%
  ------------------------------------------------------- ------------ ------ ------ ------ ------ ------ ------ ------ ------ ------- ---------
  BioMed Central (Springer)                               174          7      20     16     12     20     22     8      15     294     69
  Hindawi Limited                                         76           15     17     31     9      18     27     20     14     227     200
  Multidisciplinary Digital Publishing Institute (MDPI)   27           10     28     39     20     8      9      23     9      173     540
  SpringerOpen                                            18           5      2      46     2      20     29     25     23     170     840
  Frontiers Media S.A.                                    17           7      1      2      12     7      4      3      \-     53      211
  Copernicus Publications                                 18           4      \-     2      1      6      3      2      2      38      110
  African Online Scientific Information Systems (AOSIS)   10           \-     3      6      \-     1      9      5      1      35      250
  Nature Publishing Group (Springer)                      7            \-     2      2      1      5      4      \-     1      22      210
  Public Library of Science (PLOS)                        7            \-     \-     \-     \-     \-     \-     \-     \-     7       0
  International Union of Crystallography                  1            \-     \-     \-     1      1      1      \-     \-     4       300
  Others (147)                                            108          31     33     32     28     30     40     25     30     359     230
  **Total**                                               463          79     106    176    86     116    148    111    95     1380    190

1.  SpringerOpen is a new brand name that retains the prestige of a traditional publisher while increasing the number of titles in open access by 800% in 8 years without ceasing or changing its activities with subscription journals. If we consider Springer also owns Nature, BioMed Central and part of Frontiers Media, it is the company with the fastest growing number of Open Access journals. This requires enormous investments and highly qualified professionals and is part of the company's strategic plan.

2.  The year with the most significant growth was 2013, coinciding with changes to DOAJ including the introduction of more rigorous criteria for admitting new titles and the creation of the Seal \[[@pone.0233432.ref030]\].

3.2 Distribution of knowledge areas and publishers with the DOAJ Seal {#sec005}
---------------------------------------------------------------------

[Table 3](#pone.0233432.t003){ref-type="table"} shows Medicine is the most prevalent knowledge area in the sample, with almost half of the titles and 40% of the articles, reflecting a proportion similar to the general situation of journals and articles. It is followed by science and technology with 25% of the titles and 21% of the articles. Differences in the categorization of knowledge areas among indexers makes them difficult to compare, but medicine is invariably the biggest area in every study of scientific journals and articles. This predominance is also found among publishers that already have a tradition in the area and have migrated their journals to the Open Access option, like BMC and Nature. However, new players like MBPI and AOSIS show a more balanced representation of areas.

10.1371/journal.pone.0233432.t003

###### Distribution of publisher's titles and articles with the DOAJ Seal by knowledge area.
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  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Knowledge areas Publisher                               Agriculture   Medicine   Science   Technology   Others   294\                                                                    
                                                                                                                   Total 295                                                               
  ------------------------------------------------------- ------------- ---------- --------- ------------ -------- ----------- -------- ----- -------- ----- ------------ ------ --------- ------
  African Online Scientific Information Systems (AOSIS)   1708          2          5752      11           3435     3           2266     2     13319    17    **26480**    2.2    **35**    2.5

  BioMed Central -Springer                                6764          10         141630    218          21457    42          11765    15    1918     9     **183534**   15.0   **294**   21.3

  Copernicus Publications                                 246           1          \-        \-           28720    17          20468    12    5439     8     **54873**    4.5    **38**    2,7

  Frontiers Media S.A                                     9435          2          44849     24           32543    14          2112     7     13793    6     **102732**   8.4    **53**    3.8

  Hindawi Limited                                         1557          7          86750     129          57095    53          40912    35    533      3     **186847**   15.3   **227**   16.4

  International Union of Crystallography                  \-            \-         \-        \-           26799    4           \-       \-    \-       \-    **26799**    2.2    **4**     0,3

  Multidisciplinary Digital Publishing Institute (MDPI)   2841          6          23252     29           79068    57          81028    53    11076    28    **197265**   16.2   **173**   12.5

  Nature Publishing Group---Springer                      \-            \-         22895     9            404      6           319      6     16       1     **23634**    1.9    **22**    1.6

  Public Library of Science (PLOS)                        \-            \-         220580    4            19045    3           \-       \-    \-       \-    **239625**   19.6   **7**     0.5

  SpringerOpen                                            520           6          2533      31           14124    29          14300    61    4276     43    **35753**    2.9    **170**   12.3

  Others (147)                                            3517          8          30975     74           29509    60          8404     20    70471    197   **142876**   11.7   **359**   25.9

  Total                                                   26588         42         579216    529          312199   288         181574   211   120841   312   1220418      100    1382      100

  **%**                                                   2.2           3          47.5      38           25,6     21          15       15    10       22    100          \-     100       \-
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Data collected by the authors. Art = articles, Tit = titles

SpringerOpen has a remarkably small number of titles in the field of medicine, focusing instead on science and technology. This is probably due to Springer's merger with Nature, which is already a major player in medicine. It is important to note the impressive growth of new titles from Springer with consequences that can affect to the scientific community (to publish a huge number of journals is relevant for controlling knowledge areas). It also raises the question of how a company that is creating such an impressive number of new journals could be meeting the challenge of publishing enough good quality articles in their first years before they can be indexed in databases like WoS or Scopus. The wave of "predatory lists" of open access publishers in recent years, which have called into question the reputability of many new journals, especially from peripheral countries, is also relevant to this issue, despite the fragilities (not reliable, nor transparent, have flaws and need to be updated constantly) of these lists \[[@pone.0233432.ref031]\], \[[@pone.0233432.ref032]\].

Another option for growth is through partnerships with societies, as described by Mathias, Jahn and Laakso (2019, p. 22) \[[@pone.0233432.ref012]\]: "Through publishing partnerships, societies gain access to technical infrastructure and marketing resources, but are also subject to the publisher's policies and regulations. In particular, the inclusion in a journal package can have positive and negative implications, as discounted subscription fees of 'big deals' can affect the societies' revenue share."

1.  Partnerships between commercial publishers and non-commercial institutions are a common practice that complicates classification and analysis. According to Crawford (2018, p. 20) \[[@pone.0233432.ref033]\], "there are 13 publisher names in the APCLand group (Springer, Nature and BioMed Central are listed separately in DOAJ) and one anomaly: because of its large stable of society-sponsored journals, Elsevier appears to have published more no-fee than fee 2017 articles in gold OA journals (a few more: 899 out of nearly 30,000)."

2.  The high concentration of journals controlled by commercial publishers may generate an oligopoly equivalent at the one in the subscription model, since the concentration by commercial publishers in DOAJ Seal replicates in small scale the traditional publishing market \[[@pone.0233432.ref022]\]. This is more obvious in "core" areas like medicine and science and technology; it seems that the number of humanities journals was comparatively low in the traditional print era and are is similarly small in the open digital publishing era, or that financial interest is simply lower in the humanities. Small publishers cover the widest diversity of areas.

3.3 APCs charged by journals and publishers with the DOAJ Seal {#sec006}
--------------------------------------------------------------

[Table 4](#pone.0233432.t004){ref-type="table"} shows that 28% of journals don't charge APCs and our analysis found that small publishers, probably operated by associations and universities, are more likely not to charge APCs (although there is almost 50% of SpringerOpen titles with no APCs).

10.1371/journal.pone.0233432.t004

###### Number of titles by publishers and APCs in USD.
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  Publisher                                               No APC   0--500   501--1000   1001--1500   1501--2000   \>2001   Total                                        
  ------------------------------------------------------- -------- -------- ----------- ------------ ------------ -------- ------- ----- ----- ------ ---- ----- ------ ------
  African Online Scientific Information Systems (AOSIS)   12       0.9      23          1.6          \-           \-       \-      \-    \-    \-     \-   \-    35     2.5
  BioMed Central (Springer)                               17       1.2      \-          \-           9            0.6      12      0.9   245   17.7   11   0.8   294    21.3
  Copernicus Publications                                 10       0.7      5           0.4          8            0.6      15      1.1   \-    \-     \-   \-    38     2.7
  Frontiers Media S.A                                     \-       \-       \-          \-           3            0.2      7       0.5   20    1.5    23   1.7   53     3.8
  Hindawi Limited                                         2        0.5      31          2.2          135          9.8      36      2.6   22    1.6    1    0.1   227    16.4
  International Crystallography                           \-       \-       3           0,2          \-           \-       1       0.1   \-    \-     \-   \-    4      0.3
  Multidisciplinary Digital Publishing Institute (MDPI)   48       3.5      50          3.6          40           2.9      20      1.5   15    1.1    \-   \-    173    12.5
  Nature Publishing Group (Springer)                      \-       \-       \-          \-           \-           \-       \-      \-    4     0.3    18   1.3   22     1.6
  Public Library of Science (PLOS)                        \-       \-       \-          \-           \-           \-       1       0.1   \-    \-     6    0.4   7      0.5
  SpringerOpen                                            81       5.9      \-          \-           32           2.3      42      3     14    1      1    0.1   170    12.3
  Others (147)                                            208      15       66          4.8          38           2.7      32      2.3   8     0.6    7    0.5   359    26
  **Total**                                               378      27.6     178         12,9         265          19.2     166     12    328   23.7   67   4.8   1382   100

Data collected by the authors

[Table 4](#pone.0233432.t004){ref-type="table"} confirms Holley's assertion (2018, p. 236) \[[@pone.0233432.ref023]\] that

"\[t\]he most critical development in publishing has been the ability of large commercial publishers to find ways to profit from open access. While the original intent of open access was to limit or destroy their monopoly, the exact opposite has happened. They have created a new revenue stream from gold APCs while still mostly retaining their subscriptions for paywalled publications, even in hybrid journals.

The complexity of adding open access to the scholarly communication system has induced much smaller scholarly and other publishers to agree to be partners by these large publishers, which has only increased their competitive dominance. Without some major unexpected change, open access, paywalled, and hybrid journals will coexist for the near future."

59% of journals charge APCs of less than US\$1,000, confirming that it is possible to have quality journals charging reasonable fees. The high number of titles with no fees in important areas requires a more detailed analysis, preferably a longitudinal one, because APCs may be introduced by journals as they evolve and their position in the rankings changes. Mathias, Jahn and Laakso (2019, p. 22) \[[@pone.0233432.ref012]\] comment that

"commercial publishers have generally been slow in flipping subscription journals to OA at a larger scale, and, more notably, have instead resorted to creating new OA journals, or acquiring established OA journals and entire publishers (e.g., BioMed Central, Co-Action, Dove Medical Press, Medknow). Another expression of this reluctant stance to flipping is the emergence of so-called mirror journals: new fully OA journals that capitalize on existing subscription journals. Instead of converting the subscription journal to OA, a separate OA version runs alongside it, sharing the same aims and scope, almost the same name, an identical editorial board, and the same submission system (e.g., the newly founded Research Policy X and Water Research X journals by Elsevier). While not technically hybrid OA anymore, the strategic function of mirror journals for publishers appears similar: retaining the subscription-based core of the business while selling optional OA and potentially circumventing the hybrid ban that has become part of some funding policies."

For commercial publishers, revenues from subscription journals are much more significant than what they receive from Open Access. According to SPARC (2019, p. 25) \[[@pone.0233432.ref025]\] revenues from Springer's Nature journals division are 1,164,400,000 euros and revenues from articles are 4,386 euros. The proportions are similar for Elsevier and Wiley. Lawson, Gray and Mauri's suggestion (2016, p. 25) \[[@pone.0233432.ref034]\] of a "systemic opacity both within institutions as well as regarding the 'black box' of finances around scholarly communication in the UK as a whole" can be applied to the global scenario. Since revenues from open access articles are so insignificant compared to subscriptions for commercial publishers, there is no incentive to abandon traditional subscription journals while they continue to be profitable, even though the value of the open option is not small. [Table 4](#pone.0233432.t004){ref-type="table"} shows that more than 28% of titles charge more than US\$1,500 per article, and almost 5% charge more than US\$2,000 per article published. The highest prices are imposed by Springer Nature, with 80% of its journals charging more than US\$2,000 an article, and Springer's BioMed Central, with 87% of its titles charging more than US\$1,500. SpringerOpen, has no charges for 47% of its titles, reflecting a very different price strategy.

A connection can be identified between these results and the age of the titles presented in [Table 1](#pone.0233432.t001){ref-type="table"}. Springer's BioMed Central had the highest number of titles in 2010 and is a consolidated publisher that has been growing constantly since that year. Springer Nature is also a traditional publisher that has tripled the number of titles it has with the DOAJ Seal since 2010. The more recent titles come from SpringerOpen, which charges little or nothing for most of its new journals, probably just until they are consolidated in the "market". It is important to note that there is no control over the prices that journals can charge.

There are two possible explanations for commercial publishers making their titles in Open Access free of charge: a) they are in partnerships with a scientific society that pays the costs; or b) the titles are free until they are indexed in a relevant database and/or have achieved a reasonable level of prominence in the area, at which time fees may be introduced. This is an established strategy to conquer and control new markets and that is being used in various areas \[[@pone.0233432.ref035]\]. New studies of this situation are needed to clarify these practices.

The relationship between knowledge areas and APC amounts was analyzed to identify possible patterns ([Table 5](#pone.0233432.t005){ref-type="table"}). The most surprising result was the percentage of free APC titles, totaling 27% in all areas. The least represented areas are humanities and social sciences, although the use by DOAJ of the Knowledge Areas distribution from the American Library difficult a global analysis, since they do not have equivalence with other classifications.

10.1371/journal.pone.0233432.t005

###### Article Processing Charges of Journals with the DOAJ Seal by knowledge area (in USD).
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  Knowledge area                   No APC   1--500   501--1000   1001--1500   1501--2000   \>2001   Total                                         
  -------------------------------- -------- -------- ----------- ------------ ------------ -------- ------- ------ ----- ------ ---- ----- ------ ------
  Agriculture                      11       0.8      5           0.4          12           0.9      3       0.2    9     0.6    2    0.2   42     3.1
  Auxiliary History                3        0.2      5           0.4          0            0.0      1       0.1    0     0.0    0    0.0   9      0.6
  Bibliography/Library             10       0.7                  0.0                       0.0              0.0          0.0         0.0   10     0.7
  Education                        28       2.0      4           0.3          5            0.4      3       0.2    2     0.2    1    0.1   43     3.1
  Fine Arts                        14       1.0      1           01           3            0.2      1       0.1          0.0         0.0   19     1.4
  General Works                    7        0.5      4           0.3          2            0.2              0.0    2     0.4         0.0   15     1.1
  Geography/Anthropology           18       1.3      6           0.4          8            0.6      7       0.5    3     0.2         0.0   42     3.1
  History                          10       0.7      1           0.1                       0.0              0.0          0.0         0.0   11     0.8
  American History                 6        0.4                  0.0                       0.0              0.0          0.0         0.0   6      0.4
  Language and Literature          24       1.7      5           0.4          1            0.1      1       0.1          0.0         0.0   31     2.2
  Law                              11       0.8      2           0.2                       0.0              0.0          0.0         0.0   13     1.0
  Medicine                         62       4.5      52          3.8          113          8.2      45      3.3    196   14.2   61   4.4   529    38.3
  Music                            2        0.2                  0.0                       0.0              0.0          0.0         0.0   2      0.2
  Naval Science                             0.0                  0.0          1            0.1              0.0          0.0         0.0   1      0.1
  Philosophy/Psychology/Religion   13       0.9      8           0.6          4            0.3      3       0.2    1     0.1    2    0.2   31     2.2
  Political Science                10       0.7      2           0.2          1            0.1      1       0.1          0.0         0.0   14     1.0
  Science                          48       3.5      48          3.5          65           4.7      50      3.6    52    3.8    25   1.8   288    20.8
  Social Sciences                  37       2.7      14          1.0          9            0.6      6       0.4          0.0         0.0   66     4.8
  Technology                       64       4.6      21          1.5          46           3.3      45      3.2    28    2.0    7    0.5   211    15.3
  Total                            378      27.3     178         12.8         270          19.5     166     12.0   293   21.2   98   7.1   1383   100

Data collected by the author

The area with the most expensive titles is medicine, with around 50% of titles charging more than US\$1,500 to publish an article. Science and technology follows with a more balanced range of charges. All areas have a few titles with no charges. However, in education, language and literature, and social sciences most titles have no fees and just a few charges more than US\$1,000 per article. It is important to remember, however, that a journal may change its APC policy as it evolves, as its impact grows.

APC pricing is connected with the publisher's policy and interests. The creation of new marketing models affects all prices. Springer's new Read and Publish (RAP) option, which combines OA publishing in hybrid journals with access to subscription content in one agreement and one fee customized for each institution \[[@pone.0233432.ref036]\] or country, will add even more complexity and dependence to already opaque pricing practices and dominated by oligopolies market.

The time required for publication is an increasing concern for scientists, who depend on articles to document their research. Publication is a crucial part of a researcher's career and, as Ellers, Crowther and Harvey (2017, p. 97) \[[@pone.0233432.ref029]\] note, "\[a\]s increased pressure to publish is a general pattern in academia, it makes the high acceptance rates and rapid review system of mega-journals increasingly attractive."

Rapid publication shortens the time for peer review, which may raise concerns about the rigor of the review, as shown in [Table 6](#pone.0233432.t006){ref-type="table"}. Our analysis of the time for publication among DOAJ Seal journals reveals considerable diversity. The shortest publication time in the sample is 5 weeks, which may be considered a very short time to complete the whole review process. The biggest proportion of titles (32%) are in the 11--13 week range. Journals with the most expensive APCs take 14 weeks to publish an article while the cheapest journals (under 500\$) take around 10 to 13 weeks. The longest time we considered relevant is 30 weeks; a total of 61 titles had publication times longer than 31 weeks, representing 4.4% of the total. We were unable to identify any causal relationship between APC price and time for publication.

10.1371/journal.pone.0233432.t006

###### DOAJ Seal journal times for publication (in weeks) and APC values (in USD).

![](pone.0233432.t006){#pone.0233432.t006g}

               APC values in US\$                                                            
  ------------ -------------------- ------- ----- ------- ----- ------- ----- ------- ------ -------
  5 or less    24                   1.01    7     0.36    5     0.29    8     0.51    44     2.17
  6            32                   2.32    7     0.51    5     0.36    10    0.72    54     3.91
  7            9                    0.65    2     0.14    \-    \-      8     0.58    19     1.37
  8            21                   1.52    3     0.22    4     0.29    14    1.01    42     3.04
  9            6                    0.43    \-    \-      3     0.22    12    0.87    21     1.52
  10           40                   2.89    17    1.23    4     0.29    12    0.87    73     5.28
  11           76                   5.50    47    3.40    22    1.59    26    1.88    171    12.37
  12           65                   4.70    7     0.51    12    0.87    33    2.39    117    8.47
  13           67                   4.85    35    2.53    34    2.46    29    2.10    165    11.94
  14           9                    0.65    20    1.45    10    0.72    44    3.18    83     6.01
  15           24                   1.74    13    0.94    14    1.01    14    1.01    65     4.70
  16           27                   1.95    11    0.80    9     0.65    21    1.52    68     4.92
  17           8                    0.58    20    1.45    3     0.22    17    1.23    48     3.47
  18           3                    0.22    21    1.52    6     0.43    16    1.16    46     3.33
  19           9                    0.65    10    0.72    4     0.29    17    1.23    40     2.89
  20           35                   2.53    10    0.72    2     0.14    19    1.37    66     4.78
  21           6                    0.43    13    0.94    1     0.07    12    0.87    32     2.32
  22           7                    0.51    4     0.29    3     0.22    9     0.65    23     1.66
  23           3                    0.22    3     0.22    1     0.07    16    1.16    23     1.66
  24           13                   0.94    2     0.14    2     0.14    14    1.01    31     2.24
  25           5                    0.36    2     0.14    1     0.07    5     0.36    13     0.94
  26           8                    0.58    2     0.14    \-    \-      5     0.36    15     1.09
  27           2                    0.14    1     0.07    \-    \-      4     0.29    7      0.51
  28           1                    0.07    5     0.36    3     0.22    12    0.87    21     1.52
  29           3                    0.22    \-    \-      \-    \-      \-    \-      3      0.22
  30           14                   1.01    3     0.22    1     0.07    3     0.22    21     1.52
  31 or more   39                   2.8     4     0.3     17    1.2     11    0.8     61     4.4
  **Total**    556                  40.23   269   19.46   166   12.01   391   28.29   1380   100

4 Conclusion {#sec007}
============

Our analysis of journals registered with the DOAJ Seal reveals a remarkable concentration of ownership. The four biggest commercial publishers are responsible for 63% of the titles indexed with the DOAJ Seal. If we add together the figures for all publishers owned by Springer (BioMed Central, SpringerOpen, and Nature), we find 35% of journals and 65% of articles in just one company. *PLOS One* alone has more articles than all the small publishers put together. If we consider the other commercial publishers that have titles in OA, the concentration of the oligopoly is even denser than the general publishing market. The concentration replicates in small scale the traditional publishing market, where just 8% of the titles are in Gold Open Access. Since it is the owners of the journals that determine the creation of new titles and the acceptance policies for papers in each knowledge area, it is reasonable to conclude that academia has little control over the scope of the journals or the creation of new titles, as these are subject to the diverse interests of commercial publishers.

In relation to this oligopoly, Larivière, Haustein and Mongeon (2015, p. 108) \[[@pone.0233432.ref019]\] conclude that "the role of universities and research councils cannot be over-emphasized, as they are at the heart of the research evaluation system and decide what has value. Should they create incentives for scholars to publish in open access, not-for-profit journals---rather than focusing on Impact Factors or university rankings, which clearly favor big publishers---the research community could regain control of the scholarly communication system."

Fyfe et al. (2017, p. 19) \[[@pone.0233432.ref037]\] are clear about the solution to this situation: "universities and learned societies are the key institutions that reward academics and should have an active role to play in creating a non-profit, online model for academic publishing that meets academic desires both to circulate and share knowledge widely and to gain prestige among peers. They could do this by offering direct support for non-profit publishers (which deliver better value for money), or by harnessing emerging technologies to establish their own publishing venues."

The identification of a wide range of APC amounts and a correlation of those amounts with the age of the titles of DOAJ seal but not with the knowledge areas or the time for publication raises questions about the strategies for the creation of new journals and their consequences for the scientific community in the long term. The results allow us to conclude that there is an oligopoly of commercial publishers trying to control the scientific communication system, creating a level of dependence where researchers have little power to decide what and where to publish since their institutions expect publications in journals with high Impact Factors that are not necessarily the best ones to dialogue with their peers, or they may have"deals" with certain journals in which their researchers are expected to publish their work. This interference in researchers' decisions of where to publish undermines the freedom and autonomy of science, quite apart from the already well-known problem of abusive prices.

10.1371/journal.pone.0233432.r001
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Open access publishers: the DOAJ Seal profile

PLOS ONE

Dear Dr Abadal,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Your manuscript has been scientifically judged by two acknowledged experts in the area. Both them have remarked the overall merit of the submitted work, and (based in my own assessment) I should say that this paper has a good potential for being considered as publishable in PLOS ONE. Nevertheless, you will find some comments (below) suggesting many improvements (some of them major) that need to be addressed through a revision of the paper.

Please perform a careful and complete revision of all these queries, comments and suggestion, and try to support as good as possible the statements contained in your rebuttal letter (and in the revised text), detailing all the modifications and improvements done.

We would appreciate receiving your revised manuscript by Apr 04 2020 11:59PM. When you are ready to submit your revision, log on to <https://www.editorialmanager.com/pone/> and select the \'Submissions Needing Revision\' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: <http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols>

Please include the following items when submitting your revised manuscript:

A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled \'Response to Reviewers\'.A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled \'Revised Manuscript with Track Changes\'.An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled \'Manuscript\'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Sergio A. Useche, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

Please ensure that your manuscript meets PLOS ONE\'s style requirements, including those for file naming. The PLOS ONE style templates can be found at

<http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf> and <http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf>

1\. Please consider changing the title so as to meet our title format requirement (<https://journals.plos.org/plosone/s/submission-guidelines>). In particular, the title should be \"Specific, descriptive, concise, and comprehensible to readers outside the field\" and in this case it is not informative and specific about your study\'s scope and methodology.

2\. We note you have included tables to which you do not refer in the text of your manuscript. Please ensure that you refer to Tables 2,3,5,6 in your text; if accepted, production will need this reference to link the reader to the Table.

\[Note: HTML markup is below. Please do not edit.\]

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Partly

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

2\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: There is some interesting analysis here that adds to the understanding of open access and DOAJ's role in helping identify high quality OA journals. The paper seems incomplete, however. Additional analysis, substantiation of several claims, and expanding the description of publishers would make this a better paper. In addition, the introduction to DOAJ should be expanded for those readers who are not familiar with it. See some details below.

Lines 176, 177, 178. This statement is confusing and unsubstantiated. I suggest deleting it. You can just end the paragraph without it or find and cite a source that offers a substantiated version of what you are trying to say about novelty. Equating lack of novelty with higher quality and duplication confuses issues as it is stated. If the statement is rewritten and a source cited that supports it, note that "brings" should be "bring" in line 177.

In the introduction you mention that 3 large commercial publishers dominate the publishing industry/number of titles. In the findings you mention that PLOS and Biomed Central, MDPI and Hindawi in addition to Springer dominate the findings. You need to describe these publishers more and earlier in terms of commercial or non-profit, subject matter, etc. I would suggest expanding the introductory section on publishers to give more details rather than just those top 3 so the publishers you mention in the findings are not completely new to the reader when we reach this point. Perhaps a table of publishers would help. (For example, an extension of Table 1 in <https://www.stm-assoc.org/2018_10_04_STM_Report_2018.pdf>

Lines 200+ you mention some characteristics, but information about publishers is scattered, so this introduction would help readers put these scattered statements into context.

Your Table 1: should be titled "...by the Biggest Open Access Publishers"

It seems that Table 2 should logically come before Table 1.

Lines 257-260: This comment is unsubstantiated and should be supported or deleted. It is jarring and seemingly irrelevant. 257 "This highlights what appears

258 to be the real motivation behind the creation of new journals in Open Access: the

259 company's portfolio interests in the market, rather than the needs of society or the

260 pursuit of scientific innovation."

Line 269: Also see: Shen, C., & Björk, B.-C. (2015). 'Predatory' open access: a longitudinal study

of article volumes and market characteristics. BMC Medicine, 13(230), 1-15. doi:

10.1186/s12916-015-0469-2

You should expand the discussion of predatory OA and how DOAJ hopes to provide a "white list" that eliminates those.

Since in your conclusion (lines 283-285) you make a bold prediction (283: "The high concentration of journals controlled by commercial publishers may

284 generate a price crisis in the Open Access movement similar to that of the 1960s, when

285 prices rose so high that libraries were forced to cancel subscriptions.") you need to include analysis on prices. This statement again needs evidence and your study is in a position to do so, or at least include references and a discussion of price studies by others.

In summary: include characteristics of publishers in introductory section, remove or substantiate several statements that are not substantiated by evidence from data analysis or literature review, add to the literature and discussion on predatory journals and how DOAJ serves as a white list to help authors select reputable OA journals.

Reviewer \#2: This manuscript represents an interesting analysis of the publishers business model and journals\' behaviour respect to some critical variables in the OA era. Focussing on the DOAJ seal is a good point of analysis. The overall manuscript is well-written, the aims of the study and the conclusions are consistent.

just a few observations:

2.Methodology section: when you give numbers, please specify the date of your search as nowaday the numbers are different, of course, even if slightly.

3.1: the observation of lines 210-212 deserves to be stressed also in the conclusion section because is very meaningful!

3.2 Distribution of knowlege areas, line 257-260: this statement is more a consideration than a description. you could put it in the Results and Discussion section.

Just a final observation: discussing about PLOSone in PLOSone\...I think your analysis is quite objective but\...

in conclusion, it\'s a manuscript, very interesting to be read!

\*\*\*\*\*\*\*\*\*\*

6\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.

10.1371/journal.pone.0233432.r002
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Response to reviewers

1\. Please consider changing the title so as to meet our title format requirement (<https://journals.plos.org/plosone/s/submission-guidelines>). In particular, the title should be \"Specific, descriptive, concise, and comprehensible to readers outside the field\" and in this case it is not informative and specific about your study\'s scope and methodology.

We have changed it. We propose three options but we are open to new suggestions coming from the reviewers or the editors.

2\. We note you have included tables to which you do not refer in the text of your manuscript. Please ensure that you refer to Tables 2,3,5,6 in your text; if accepted, production will need this reference to link the reader to the Table.

Revised.

Reviewer \#1

There is some interesting analysis here that adds to the understanding of open access and DOAJ's role in helping identify high quality OA journals. The paper seems incomplete, however. Additional analysis, substantiation of several claims, and expanding the description of publishers would make this a better paper.

Ok, we answer your comments below.

In addition, the introduction to DOAJ should be expanded for those readers who are not familiar with it. See some details below.

We have added more details about DOAJ (line 113).

Lines 176, 177, 178. This statement is confusing and unsubstantiated. I suggest deleting it. You can just end the paragraph without it or find and cite a source that offers a substantiated version of what you are trying to say about novelty. Equating lack of novelty with higher quality and duplication confuses issues as it is stated. If the statement is rewritten and a source cited that supports it, note that "brings" should be "bring" in line 177.

Deleted.

In the introduction you mention that 3 large commercial publishers dominate the publishing industry/number of titles. In the findings you mention that PLOS and Biomed Central, MDPI and Hindawi in addition to Springer dominate the findings. You need to describe these publishers more and earlier in terms of commercial or non-profit, subject matter, etc. I would suggest expanding the introductory section on publishers to give more details rather than just those top 3 so the publishers you mention in the findings are not completely new to the reader when we reach this point. Perhaps a table of publishers would help. (For example, an extension of Table 1 in <https://www.stm-assoc.org/2018_10_04_STM_Report_2018.pdf>

We have included a list of the current biggest academic publishers according to Ulrich's and a new paragraph analyzing the most prominent open access publishers (line 71).

Lines 200+ you mention some characteristics, but information about publishers is scattered, so this introduction would help readers put these scattered statements into context.

We agree on that, thanks.

Your Table 1: should be titled "...by the Biggest Open Access Publishers"

Added.

It seems that Table 2 should logically come before Table 1.

We do not agree with that. We think that table 1 is more general and offers a global overview of the publisher's scenario. Table 2 includes just the years.

Lines 257-260: This comment is unsubstantiated and should be supported or deleted. It is jarring and seemingly irrelevant. 257 "This highlights what appears 258 to be the real motivation behind the creation of new journals in Open Access: the 259 company's portfolio interests in the market, rather than the needs of society or the 260 pursuit of scientific innovation."

Deleted.

Line 269: Also see: Shen, C., & Björk, B.-C. (2015). 'Predatory' open access: a longitudinal study

of article volumes and market characteristics. BMC Medicine, 13(230), 1-15. doi:

10.1186/s12916-015-0469-2

You should expand the discussion of predatory OA and how DOAJ hopes to provide a "white list" that eliminates those.

We have added this reference beneath a previous one (Somoza et al, 2018). We have included also a comment about the role of DOAJ against predatory journals ("white list").

Since in your conclusion (lines 283-285) you make a bold prediction (283: "The high concentration of journals controlled by commercial publishers may generate a price crisis in the Open Access movement similar to that of the 1960s, when prices rose so high that libraries were forced to cancel subscriptions.") you need to include analysis on prices. This statement again needs evidence and your study is in a position to do so, or at least include references and a discussion of price studies by others.

We have changed the sentence and the argument and we have added the reference to Khoo, S.Y.-S., 2019.

In summary: include characteristics of publishers in introductory section, remove or substantiate several statements that are not substantiated by evidence from data analysis or literature review, add to the literature and discussion on predatory journals and how DOAJ serves as a white list to help authors select reputable OA journals.

Ok, thanks for your comments.

Reviewer \#2:

This manuscript represents an interesting analysis of the publishers business model and journals\' behaviour respect to some critical variables in the OA era. Focusing on the DOAJ seal is a good point of analysis. The overall manuscript is well-written, the aims of the study and the conclusions are consistent. Just a few observations:

2.Methodology section: when you give numbers, please specify the date of your search as nowaday the numbers are different, of course, even if slightly.

Changed (line 127 ... "in March of 2019".)

3.1: the observation of lines 210-212 deserves to be stressed also in the conclusion section because is very meaningful!

We have added a comment in the conclusions (line 440)

3.2 Distribution of knowledge areas, line 257-260: this statement is more a consideration than a description. you could put it in the Results and Discussion section.

We agree on that, but this statement is now in the Results and Discussion section. This consideration or reflection is based on the data collected and starts a relevant discussion.

Just a final observation: discussing about PLOSone in PLOSone\...I think your analysis is quite objective but\... in conclusion, it\'s a manuscript, very interesting to be read!

Thanks for your comments. We have tried to discuss about open access publishers and PLOSOne is part of this reality. We think also that it is a good journal to send our manuscript and for improving it (correcting any bias or problem) with the help of our reviewers.

###### 

Submitted filename: Response-to-reviewers.docx

###### 

Click here for additional data file.
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PLOS ONE

Dear Dr Abadal,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Firstly, I would like to acknowledge the pertinence and quality of the amendments and clarifications, as well as the responses provided to our two reviewers. Both have expressed their satisfaction in regard to the work done during the revisions of your paper. You will find below (please see the comments from Reviewer \# 2) an additional minor comment that, I believe, requires your attention and could maximize the value of the paper. Once received your revised manuscript, I will assess it and immediately proceed to make an editorial decision without needing an additional round of reviews.

We would appreciate receiving your revised manuscript by Jun 07 2020 11:59PM. When you are ready to submit your revision, log on to <https://www.editorialmanager.com/pone/> and select the \'Submissions Needing Revision\' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: <http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols>

Please include the following items when submitting your revised manuscript:

A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled \'Response to Reviewers\'.A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled \'Revised Manuscript with Track Changes\'.An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled \'Manuscript\'.
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